Biotechnology News

Cutting edge news about companies engaged in the research and development of new drugs, medical devices and procedures as well as research, books and information on FDA approvals, patents and awards. Biotechnology news highlights the use of biological processes, organisms or systems to manufacture products that improve the quality of life.

New York Cancer & Blood Specialists Opens in Forest Hills

New York Cancer & Blood Specialists (NYCBS), one of the Nation’s leading oncology practices, is now providing state-of-the-art cancer care services at 96-10 Metropolitan Ave, Forest Hills, NY 11375. The newest location will provide cutting-edge cancer treatment, making it NYCBS’s... - May 17, 2021 - New York Cancer & Blood Specialists

BDA Expands Senior Team: Sanjay Singh Joins as Head of BDA India

BDA Partners is pleased to announce that Sanjay Singh has joined the firm as Managing Director and Head of BDA, India. He will lead the Mumbai office with BDA’s existing senior bankers in India. He will also co-head BDA’s Asian Healthcare team. Sanjay has over 20 years’... - May 17, 2021 - BDA Partners Ltd

Advanced Silicon Group Closes Seed Preferred Equity Offering and Adds Alan Watson and Sarah Kelly to Board

Advanced Silicon Group, Inc. (ASG), a pioneer in silicon nanotechnology focused on developing novel biosensors, announced today the closing of a $1,020,000 seed preferred stock offering led by Cherrystone Angel Group with participation by MIT Alumni Angels of Northern California, Sidecar Angels and other private investors and the addition of two new Directors, Alan Watson, PhD, MBA and Sarah Kelly, PhD to its Board of Directors. - May 16, 2021 - Advanced Silicon Group

Cayman Develops Powerful, New Multiplex ELISA for Autoantibody Detection

Cayman Chemical's new Q-Plex™ Autoantibody Detection 10-Plex Panel, developed in collaboration with Quansys Biosciences, offers standardized, multiplex capabilities for the concurrent analysis of ten prominent analytes associated with rheumatoid arthritis or other autoimmune diseases. This... - May 16, 2021 - Cayman Chemical Company

The Brooklyn Cancer Center Announces New Chief of Hematology-Oncology

The Brooklyn Cancer Center Announces New Chief of Hematology-Oncology

The Brooklyn Cancer Center has named noted leader and board-certified hematologist-oncologist Maxim Shulimovich, DO, as its new Chief of Hematology and Medical Oncology. His recruitment promises to lead the cancer center as a unified division to provide expert care and culturally sensitive services... - May 10, 2021 - The Brooklyn Cancer Center

Paras Biopharmaceuticals Finland Oy is Named as One of the Top 30 Admired Companies to Watch 2021

Paras Biopharmaceuticals Finland Oy, a fast-growing, biopharmaceutical technology development company, based in Oulu, Finland, announced today that it is named as one of the top 30 admired companies to watch during 2021, by CIO Bulletin, USA. - April 28, 2021 - Paras Biopharmaceuticals Finland Oy

Bench International Expands West Coast Presence with Linda Sierra

Bench International Expands West Coast Presence with Linda Sierra

Linda Brings Deep Industry Experience and Human Resources Expertise to Meet West Coast Talent Demands - April 26, 2021 - Bench International

CTO, Rich Goldstein, Named 2021 Digi-Tech Innovator Honoree

CTO, Rich Goldstein, Named 2021 Digi-Tech Innovator Honoree

Cancer Expert Now's Chief Technology Officer, Dr. Rich Goldstein, recognized as a 2021 Digi-Tech Innovator Honoree. - April 23, 2021 - Cancer Expert Now, Inc.

Courage Therapeutics Awarded STTR Grant to Design Novel Anorexia Drugs

Courage Therapeutics has been awarded an STTR grant by the National Insittute of Mental Health to design novel anorexia drugs. The grant is a follow-up to research by the Cone lab at the University of Michigan that recently published in Science Translational Research that MC3R is a potential target for therapeutic development in anorexia and obesity. The effort allows for an expeditious translation of basic science into eating disorders which have remained an area of significant unmet need. - April 23, 2021 - Courage Therapeutics

Immundiagnostik, Inc. Transitions to Eco-Friendly Kit Packaging to Further Support Sustainable Laboratory Initiatives

Immundiagnostik, Inc. Transitions to Eco-Friendly Kit Packaging to Further Support Sustainable Laboratory Initiatives

North American immunoassay supplier Immundiagnostik, Inc. has transitioned its ELISA and assay kit packaging to eco-friendly materials to further support sustainable laboratory initiatives. The new bio-based packaging made by Paper Foam® is 100% compostable and eco-friendly. In addition, the organization offers custom bulk packaging services for high throughput labs working to reduce their environmental impact. More information can be found at https://www.idkna.com. - April 21, 2021 - Immundiagnostik, Inc.

GeneThera, Inc. Wastewater Testing: a Way to Better Control the COVID-19 Pandemic

The global COVID-19 pandemic has demonstrated that neither current systems nor related technologies are capable of preventing or even successfully controlling the spread of zoonotic infectious agents. One of the prominent features of these infectious organisms is their ability to infect both people... - March 30, 2021 - GeneThera Inc.

Free COVID Care Delivers More than Expected, Offers Testing, Rapid Test Results and Other Options to Chicago Community

Free COVID Care Delivers More than Expected, Offers Testing, Rapid Test Results and Other Options to Chicago Community

Free COVID Care delivers services other facilities opt not to. The services are designed to quickly and efficiently mitigate the spread of the Coronavirus. - March 29, 2021 - Free COVID Care

Courage Therapeutics Raises $1M for Treatment of Anorexia Nervosa and Other Related Eating Disorders

Courage Therapeutics raised $1M towards development of treatments for eating disorders including Anorexia Nervosa, ARFID, BED and genetic obesity. The company is led by Dan Housman a parent of children with eating disorders. The round was led by Michigan Biomedical Ventures. Funding will be used to test Courage’s proprietary compounds in animal models of eating disorders. The technology is based on the research on MC3R at the University of Michigan from co-founder Dr. Roger Cone’s lab. - March 24, 2021 - Courage Therapeutics

CyboSoft Releases pH Control System Design Guide to Help Customers Comply with EPA Rules and Achieve Quick ROI

CyboSoft Releases pH Control System Design Guide to Help Customers Comply with EPA Rules and Achieve Quick ROI

CyboSoft's pH Control System Design Guide can help industrial plants meet wastewater discharge codes, save chemical reagents, and improve plant safety and productivity. - March 22, 2021 - CyboSoft

Best Health Care Website to be Named by Web Marketing Association in 25th Annual WebAward Competition

Best Health Care Website to be Named by Web Marketing Association in 25th Annual WebAward Competition

The Web Marketing Association will name the best healthcare websites of 2021 as part of their 25th annual international WebAward Competition for Web site development at www.webaward.org. The WebAwards sets benchmarks for 96 industries, including healthcare, healthcare provider, medical, medical equipment, biotechnology and pharmaceutical websites. - March 16, 2021 - Web Marketing Association

AbboMax Introduces a Panel of Monoclonal and Polyclonal Anti-Connexin Antibodies

AbboMax introduces a panel of monoclonal and polyclonal anti-connexin antibodies. There are 21 different types of connexins which are known to exist in humans and 20 types in mice. Their abnormal expression and function are associated with human hereditary diseases. AbboMax has been developing & manufacturing high performance immunoassay reagents for many years in California. - March 15, 2021 - AbboMax, Inc.

Eurofins Viracor BioPharma Launches PanCancerIQ Comprehensive Genomic Profiling Service to Advance Precision Oncology Clinical Drug Development

Eurofins Viracor BioPharma Services, a global leader in specialty bioanalytical testing services, announces the launch of their new PanCancerIQ genomic profiling test; a next-generation sequencing (NGS) service that enables comprehensive genomic profiling of tumor samples. In addition to expanding... - March 11, 2021 - Eurofins Viracor BioPharma

Best Medical Website to be Named by Web Marketing Association in 25th Annual WebAward Competition

Best Medical Website to be Named by Web Marketing Association in 25th Annual WebAward Competition

The Best Medical Websites of 2021 will be named as part of the 25th annual WebAward Competition for Web site development at www.webaward.org. The WebAwards sets benchmarks fofr excellence for 96 industries, including healthcare, healthcare provider, medical, medical equipment, biotechnology and pharmaceutical websites, based on the seven criteria of a successful web site. The deadline for medical-related websites to enter to be judged is May 28, 2021. - March 11, 2021 - Web Marketing Association

New York Cancer & Blood Specialists Announces Ruth M. Morgan, DC as Chief Research Officer

New York Cancer & Blood Specialists Announces Ruth M. Morgan, DC as Chief Research Officer

New York Cancer & Blood Specialists (NYCBS), one of the Nation’s leading oncology practices, announces Ruth M. Morgan, DC, as Chief Research Officer. In this position, Ruth will oversee all research operations, providing leadership to ensure excellence in research performance and... - March 09, 2021 - New York Cancer & Blood Specialists

Jason Amada's 5 Tips to Become a Successful Medical Rep

Jason Amada is a New York-based medical sales representative who started his career in the field of Finance. In 2019, he made the switch to medicine and considers it to be one of the best decisions of his life. His long-lost love for medicine was realized with his career transition. He has been... - March 04, 2021 - Jason Amada: Medical Sales

Ba Organics Launches Sustainable Hemp Infused Vitamin Line Called Adaptoids

Ba Organics has released an innovative line of CBD nutraceuticals called Adaptoids. The wellness tablets are the first of it's kind to deliver accurate doses of hemp-derived cannabinoids and organic whole-fruits aimed at reducing stress and providing daily antioxidant support in one. - March 03, 2021 - Ba Organics LLC

AbboMax is Pleased to Introduce the Collection of Monoclonal and Polyclonal Anti-STAT Antibodies

STAT proteins (Signal transducers and activators of transcription) are cytoplasmic transcription factors that play an essential role in transmitting signals from the cellular membrane to the nucleus. Misregulation of STAT pathway frequently leads to tumorogenesis. AbboMax introduces a panel of monoclonal and polyclonal anti-STAT antibodies. - February 27, 2021 - AbboMax, Inc.

CloudLIMS Announces Collaboration with Folio for Secure Issuance of COVID-19 Results to Patients

CloudLIMS’ COVID-19 LIMS solution has integrated with Folio's mobile app to enable receiving, storing, and sharing of COVID-19 test results securely and digitally. - February 18, 2021 - CloudLIMS

Paras Biopharmaceuticals Finland Oy Affordable Healthcare Efforts Viewed in Over 90 Countries: Biosimilar Technologies Get Attention

Paras Biopharmaceuticals Finland Oy Affordable Healthcare Efforts Viewed in Over 90 Countries: Biosimilar Technologies Get Attention

Paras Biopharmaceuticals Finland Oy (Paras Biopharma) is a Finland-based microbial biologics company which focuses on the development of technologies for biosimilars and biologics in an efficient manner. The overall objective of Paras Biopharma is to enable economical production and future availability of affordable medicines for unmet medical needs. - February 17, 2021 - Paras Biopharmaceuticals Finland Oy

Riem Badr, MD, FCAP Named Chief of Pathology and Laboratory Services

Riem Badr, MD, FCAP Named Chief of Pathology and Laboratory Services

New York Cancer & Blood Specialists (NYCBS), one of the Nation’s leading oncology practices, has named board-certified hematopathologist Riem Badr, MD, FCAP, the chief of Pathology and Laboratory Services. https://nycancer.com/blog/2021/02/16/riem-badr-md-fcap-named-chief-pathology/ Dr. - February 16, 2021 - New York Cancer & Blood Specialists

Phase One Development of Rapid COVID-19 Point of Care Test Complete

Phase One Development of Rapid COVID-19 Point of Care Test Complete

Pepex Biomedical has effectively concluded first stage development efforts including successfully demonstrating working chemistry and manufacturing functionality of its existing electrochemical biosensor. - February 11, 2021 - Pepex Biomedical, Inc.

Sarah Cannon Cancer Institute at Swedish Medical Center Sheds New Light on Brain Tumors

Sarah Cannon Cancer Institute at Swedish Medical Center Sheds New Light on Brain Tumors

5-ALA Fluorescence Technique Allows More Precise Tumor Resection - February 11, 2021 - HCA HealthONE Swedish

New York Cancer & Blood Specialists Announces Richard Zuniga, MD as Chief of Research

New York Cancer & Blood Specialists Announces Richard Zuniga, MD as Chief of Research

New York Cancer & Blood Specialists (NYCBS), one of the nation’s leading oncology practices, announces Richard Zuniga, MD, as the Chief of Research. https://nycancer.com/blog/2021/02/02/chief-of-research/ Dr. Zuniga is a board-certified hematologist and oncologist at NYCBS. Before... - February 03, 2021 - New York Cancer & Blood Specialists

Kevin Sarney Joins Charles River CFO to Lead Life Sciences Practice

Kevin Sarney Joins Charles River CFO to Lead Life Sciences Practice

Charles River CFO, Inc. (CRCFO), a provider of part-time and interim CFO and accounting services, today announced Kevin Sarney has joined the leadership team as the Life Sciences Practice Leader and CFO. With over 20 years of experience in public and private life sciences companies, Kevin will lead... - January 21, 2021 - Charles River CFO

AltuCell Therapeutics Announces Proof-of-Concept in Lead Programs in Type 1 Diabetes in Human Subjects; Phase 1 Pilot in Humans Has IND Approval & Trial to Begin Shortly

AltuCell Therapeutics, Inc., AltuCell announced today the achievement of approval of IND in Italy after pre-clinical proof-of-concept based on data from its two lead programs for type 1 diabetes testing of cadaver stem cell-derived islets in both human and non-human subjects. Their capsules have been implanted in people with diabetes for 5 year, demonstrating long-term safety, with no toxicity or tissue necrosis, and no rejection in any of the patients treated. - January 15, 2021 - AltuCell Therapeutics

14 New Monoclonal Anti-Cytokeratin Antibodies from AbboMax

AbboMax adds over a dozen new anti-cytokeratin monoclonal antibodies to its inventory. Cytokeratins are proteins found in epithelium. A variety of cytokeratins can be used for subtyping various forms of epithelial differentiation or for the detection of possible sites of origin of tumors. Primary tumors usually recapitulate the cytokeratin profiles of the cells from which they are derived. They are one of the most effective epithelial differentiation and tumor markers. - January 13, 2021 - AbboMax, Inc.

Ultra-Low Temperature Freezers for Vaccine and Laboratory Cold Storage Introduced by ATS

Ultra-Low Temperature Freezers for Vaccine and Laboratory Cold Storage Introduced by ATS

ATS announces both freestanding and portable freezers for vaccines, biological materials, and biomedical uses. The ultra-low temperature freezers can continuously store biological materials, including vaccines, at temperatures as low as -86°C (-123°F) with +/- 0.1°C accuracy. - January 07, 2021 - Advanced Thermal Solutions, Inc.

Stefan Przyborski from University of Durham Invites You to Join 3D Cell Culture Virtual Conference

SMi Reports: Conference Chairman invite letter released for SMi’s 5th Annual 3D Cell Culture Virtual Conference, taking place in February 2021. - January 06, 2021 - SAE Media Group

Bench International Launches "Bank of Women"

Bench International Launches "Bank of Women"

First of Its Kind Program Features 550+ Executive Women Leaders for Board Seats and the C-Suite - January 05, 2021 - Bench International

A Novel Treatment Modality for COVID-19: Global Cancer Technology is Developing a Nanoparticle Which May Selectively Target, Bind and Inactivate Coronavirus Virions

A Novel Treatment Modality for COVID-19: Global Cancer Technology is Developing a Nanoparticle Which May Selectively Target, Bind and Inactivate Coronavirus Virions

Global Cancer Technology, an emerging biopharmaceutical company, is developing a novel treatment modality to selectively kill the COVID-19 virus. - December 30, 2020 - Global Cancer Technology

Popular Music-Fitness App, RockMyRun Releases New Poll on Music and Exercise and the Five Best Workout Songs of All Time

Popular Music-Fitness App, RockMyRun Releases New Poll on Music and Exercise and the Five Best Workout Songs of All Time

RockMyRun recently released a poll that revealed the five best workout songs of all time along with details on how important music is to a great workout. Topping the list of all-time favorite workout jams are, We Will Rock You by Queen and Lose Yourself by Eminem. - December 25, 2020 - RockMyRun

United Capital Partners Sources $10MM Equipment Lease Line

United Capital Partners Sources $10MM Equipment Lease Line

United Capital sources $10MM equipment lease line for customer in the Biotech Industry. - December 18, 2020 - United Capital Partners

The US Oncology Network Warns Administration’s Most Favored Nation Model Will Disrupt Patient Access to Cancer Treatments

The US Oncology Network Warns Administration’s Most Favored Nation Model Will Disrupt Patient Access to Cancer Treatments

Interim Final Rule would disproportionately target oncologists and reduce patient access to current and future treatments. - November 24, 2020 - The US Oncology Network

Unique New Device to Self-Monitor COVID-19 Risk During Delay Between Tests, from Centers for Age Control Inc.

Unique New Device to Self-Monitor COVID-19 Risk During Delay Between Tests, from Centers for Age Control Inc.

Few people are able to take a COVID-19 test every day or even every week or month. A negative result can be useful on the day of the test, but a person will not know if infected later. The COVID-19 HealthMeter™ reduces that risk with daily noninvasive physiological self-monitoring of 16 COVID-19 indicators and risk factors, including functional age vs. birth age, high frequency hearing loss, mental confusion, short term memory, lungs, blood oxygen, heart rate, blood pressure, body fat, etc. - November 12, 2020 - Centers for Age Control Inc.

Erica Cai Named ALPCO’s Summer 2020 Diabetes Research Travel Grant Recipient

Erica Cai Named ALPCO’s Summer 2020 Diabetes Research Travel Grant Recipient

Today ALPCO announced Erica Cai from Harvard Medical School as the latest recipient of its Diabetes Research Travel Grant. Dr. Cai is a postdoctoral fellow from the Joslin Diabetes Center researching the mechanism of autoimmunity that leads to beta cell destruction and type 1 diabetes (T1D). Dr. - November 10, 2020 - ALPCO

New Rapid COVID-19 Point of Care Test

New Rapid COVID-19 Point of Care Test

Pepex Biomedical has diverted funds and resources to the development of Multiple Rapid COVID-19 Tests designed to accurately identify Antigens (diagnostic to detect active virus) and Antibodies (to determine immunity) in under 15 minutes with 95% accuracy. - November 09, 2020 - Pepex Biomedical, Inc.

Cayman Breaks Ground on State-of-the-Art Facility Projecting Future Growth in R&D

Cayman held a groundbreaking ceremony to start the buildout of a $20 million research and development facility at its headquarters in Ann Arbor, MI. - November 07, 2020 - Cayman Chemical Company

ReproTech, Ltd. Presents Study on Important Considerations for Safe Cryogenic Shipping

ReproTech, Ltd. was honored to present an oral abstract at the virtual American Society for Reproductive Medicine (ASRM) 2020 Scientific Congress and Expo that resulted from a study designed by authors, W. Brent Hazelrigg, President and CEO; and Amy Erickson Hagen, Vice President of Quality... - October 29, 2020 - ReproTech, LLC

Artificial Intelligence Search Technology Will be Used to Help Modernize US Federal Pathology Facility

Technology developed by Canadian researchers has been adopted by the Joint Pathology Center (JPC), which has the world’s largest collection of preserved human tissue samples. The v=center will use an artificial intelligence (AI) search engine to index and search its digital archive as part of a modernization effort. The image search engine was designed by researchers at the Laboratory for Knowledge Inference in Medical Image Analysis (Kimia Lab) at the University of Waterloo. - October 28, 2020 - Kimia Lab, University of Waterloo

Cellulose Ethers Market Size, Share, and Forecast 2019-2027

Cellulose Ethers Market Size, Share, and Forecast 2019-2027

The global cellulose ethers market is valued at USD 4,292.87 million in 2019 and is expected to grow at a CAGR of 4.83%. This rise in market value can be attributed to the increase in awareness regarding the benefits of cellulose ether and its derivatives increase in the number of oil drilling activities. - October 28, 2020 - DataM Intelligence 4Market Research

The Palm Beach Hedge Fund Association Announces a Strategic Partnership with Jupiter Orphan Therapeutic

The Palm Beach Hedge Fund Association Announces a Strategic Partnership with Jupiter Orphan Therapeutic

Jupiter Orphan Therapeutics forms strategic partnership with The Palm Beach Hedge Fund Association. - October 15, 2020 - Palm Beach Hedge Fund Association

Volasertib, a Potential New Treatment for Rhabdomyosarcoma, Receives Orphan Drug Designation from the U.S. FDA

Volasertib, a Potential New Treatment for Rhabdomyosarcoma, Receives Orphan Drug Designation from the U.S. FDA

Oncoheroes Biosciences, a biotech focused on advancing new therapies for childhood cancer, today announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation (ODD) to volasertib for its use in treating pediatric rhabdomyosarcoma and other rare soft tissue sarcomas. Key... - October 15, 2020 - Oncoheroes Biosciences Inc.

Introducing EDI’s COVID-19 Nucleocapsid IgG Quantitative ELISA Kit

The EDI™ COVID-19 Nucleocapsid IgG Quantitative ELISA Kit is designed, developed & produced for the quantitative measurement of human anti-COVID-19 (anti-SARS-CoV-2) IgG antibody in serum. The test uses a series of calibrators & controls in order to determine a standard curve, which allows for specific, concentration-based results of patient samples, giving researchers & healthcare providers access to quantitative patient data in order to better understand a patient's current disease stage. - October 14, 2020 - Epitope Diagnostics, Inc.

ReproTech, Ltd. Celebrates 30 Years in Reproductive Cryostorage

ReproTech, Ltd. is celebrating 30 years as the first company dedicated solely to long-term reproductive tissue storage. Over three decades, ReproTech has expanded from one facility in St. Paul, MN to four regional locations in the United States including Fort Lauderdale, FL; Reno, NV; and... - October 14, 2020 - ReproTech, LLC

Veralize Device Team Named Semi-Finalist for XPRIZE Rapid COVID-19 Testing

Team made up of 12-15 Molecular Diagnostics, African Biosciences Ltd. and Ahmadu Bello University has been selected as semi-finalist in the XPRIZE Rapid COVID-19 Testing competition. The patented rapid response diagnostic device designed by 12-15 Molecular Diagnostics can detect COVID-19 using saliva samples. By algorithmically analyzing the results with the 12-15 Molecular Diagnostics machine learning system, the test can provide 95% accuracy and early detection, even when there are no symptom - October 13, 2020 - Alumni Solutions Ltd

Press Releases 401 - 450 of 2,335